The newly formed panel will compile and analyse data on adverse reactions, forwarding regular reports to the central ...
Adverse drug reactions (ADRs) remain a common clinical problem since they can mimic many diseases and cause significant morbidity and mortality. Judicious prescribing is important to minimize ...
Vietnam Investment Review on MSN3d
FDA Approves New Prostate Cancer Imaging Agent Gozellix®Telix Pharmaceuticals Limited today announces that the United States Food and Drug Administration has approved its New Drug ...
The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
He had taken them for a few days when he faced an adverse reaction. "I was at an event ... According to a 2024 report from the Association of American Medical Colleges, a survey of 346 medical ...
Achieved Q4 2024 PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 million; full-year 2024 net product revenue totaled $25.4 ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...
Less than three-quarters of medical device-related adverse events are reported on time by their manufacturers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback